![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Atiomo W, El-Mahdi E, Hardiman P. Familial associations in women with polycystic ovary syndrome. Fertility and Sterility 2003; 80: 143–145
- Azziz R, Kashar-Miller M D. Family history as a risk factor for the polycystic ovary syndrome. Journal of Pediatric Endocrinology & Metabolism 2000; 13: 1303–1306
- Balen A H, Conway G S, Homburg R, Legro R S. Polycystic ovary syndrome – A guide to clinical management. Taylor & Francis, London 2005; 4, 25, 29
- Benitez R, Sir-Petermann T, Palomino A, Angel B, Maliqueo M, Perez F, Calvillan M, et al. Prevalence of metabolic disorders among family members of patients with polycystic ovary syndrome. Revista Medica de Chile 2001; 129: 707–712
- British Heart Foundation. Coronary heart disease statistics. 2005, British Heart Foundation statistics 2005 [cited 29 October]. Available at: www.heartstats.org
- Currie C J, Morgan C L, Peters J R. Patterns and costs of hospital care for coronary heart disease related and not related to diabetes. Heart 1997; 78: 544–549
- Diabetes: The figures. Fact sheet 2000 [cited 28 October, 2005]. Available at: www.diabetes.org.uk
- Hardiman P, Pillay O C, Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet 2003; 361: 1810–1812
- Kaushal R, Parchure N, Bano G, Kaski J C, Nussey S S. Insulin resistance and endothelial dysfunction in the brothers of Indian subcontinent Asian women with polycystic ovaries. Clinical Endocrinology (Oxf) 2004; 60: 322–328
- Lakhani K, Prelevic G M, Seifalian A M, Atiomo W U, Hardiman P. Polycystic ovary syndrome, diabetes and cardiovascular disease: risks and risk factors. Journal of Obstetrics and Gynaecology 2004; 24: 613–621
- Lunde O, Magnus P, Sandvik L, Hoglo S. Familial clustering in the polycystic ovarian syndrome. Gynaecologic and Obstetric Investigation 1989; 28: 23–30
- Mao W, Li M, Zhao Y. Study on parents phenotypes in women with polycystic ovary syndrome. Zhonghua Fu Chan Ke Za Zhi 2000; 35: 583–585
- Mckay I C. Fisher's Exact Test for contingency tables larger than 2×2. 2005, Fisher's Exact test by Mckay's algorithm [cited 22 December, 2005]. Available at: www.anaphylaxisclinic.com/Ian
- Pierpoint T, McKeigue P M, Isaacs A J, Wild S H, Jacobs H S. Mortality of women with polycystic ovary syndrome at long-term follow-up. Journal of Clinical Epidemiology 1998; 51: 581–586
- Standard Occupational Classification 2000. User guides June 2000 [cited 19 December, 2005]. Available at: www.statistics.gov.uk
- Talbott E, Clerici A, Berga S L, Kuller L, Guzick D, Detre K, et al. Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study. Journal of Clinical Epidemiology 1998; 51: 415–422
- The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 2004; 19: 41–47
- Xita N, Tsatsoulis A. Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. Journal of Clinical Endocrinology and Metabolism 2006; 91: 1660–1666
- Yildiz B O, Yarali H, Oguz H, Bayraktar M. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2003; 88: 2031–2036